Ronan Kelly
Retired 2020
9.57L H1N1 vaccine doses supplied in state
Tausif Alam, TNN, Sep 4, 2010, 01.46am IST
PUNE: The number of H1N1 vaccine doses supplied in the state till date is 9.57 lakh. Among the cities, Pune tops the list. However, other cities which were not hit hard by the contagion are also not lagging behind.
"People's response towards vaccination has been very positive," Rajeev Dhere, senior director and head of the Serum Institute of India's H1N1 vaccine project, told TOI on Friday. Pune has been supplied 5,55,645 doses followed by Kolhapur (70,113) and Nagpur (66,820). Mumbai has been supplied 1.55 lakh doses so far, he added.
"There is a good level of awareness among people. All cities and interiors of the state have reported infection cases. Hence, people have grasped the enormity of the issue quite well. Besides, the media has played an important role in spreading awareness and the need for herd immunity to check human-to-human transmission of virus. All this has contributed to the good response to the H1N1 vaccines," said Sharad Agarkhedkar, chief of Pune chapter of the Indian Medical Association.
Intranasal vaccine has more popularity among people as it is cheaper, easier to administer and came into the market earlier, he added.
Talking about the efficacy of the vaccines, Dhere said that the intranasal vaccine has live attenuated virus. The vaccine offers protection at local level (nasal tract) as well as systemic level (blood). In case of injectable vaccine, protection is given at the level of the blood only. In the latter case, if the virus attacks a person, it will enter through the nose, multiply, infect and then get neutralised when it reaches the blood. The person will be protected overall, but may spread the disease in the initial period. The herd immunity phenomenon can only be observed with the live attenuated vaccine."
According to SII officials, the single dose vaccine developed by the SII will be available across the country by next week.
Tony Parmar, vice president of Zydus Cadila, said: "The injectable H1N1 vaccine, Vaxiflu-s, has good demand from all parts of Maharashtra." However, he added that there was no actual data on the supply.
As per the texts shared by Zydus Cadila, the Vaxiflu-S has a killed virus and is a non-infectious inactivated vaccine.
http://timesofindia.indiatimes.com/...n-state/articleshow/6488381.cms#ixzz0yVD1NpZC
Tausif Alam, TNN, Sep 4, 2010, 01.46am IST
PUNE: The number of H1N1 vaccine doses supplied in the state till date is 9.57 lakh. Among the cities, Pune tops the list. However, other cities which were not hit hard by the contagion are also not lagging behind.
"People's response towards vaccination has been very positive," Rajeev Dhere, senior director and head of the Serum Institute of India's H1N1 vaccine project, told TOI on Friday. Pune has been supplied 5,55,645 doses followed by Kolhapur (70,113) and Nagpur (66,820). Mumbai has been supplied 1.55 lakh doses so far, he added.
"There is a good level of awareness among people. All cities and interiors of the state have reported infection cases. Hence, people have grasped the enormity of the issue quite well. Besides, the media has played an important role in spreading awareness and the need for herd immunity to check human-to-human transmission of virus. All this has contributed to the good response to the H1N1 vaccines," said Sharad Agarkhedkar, chief of Pune chapter of the Indian Medical Association.
Intranasal vaccine has more popularity among people as it is cheaper, easier to administer and came into the market earlier, he added.
Talking about the efficacy of the vaccines, Dhere said that the intranasal vaccine has live attenuated virus. The vaccine offers protection at local level (nasal tract) as well as systemic level (blood). In case of injectable vaccine, protection is given at the level of the blood only. In the latter case, if the virus attacks a person, it will enter through the nose, multiply, infect and then get neutralised when it reaches the blood. The person will be protected overall, but may spread the disease in the initial period. The herd immunity phenomenon can only be observed with the live attenuated vaccine."
According to SII officials, the single dose vaccine developed by the SII will be available across the country by next week.
Tony Parmar, vice president of Zydus Cadila, said: "The injectable H1N1 vaccine, Vaxiflu-s, has good demand from all parts of Maharashtra." However, he added that there was no actual data on the supply.
As per the texts shared by Zydus Cadila, the Vaxiflu-S has a killed virus and is a non-infectious inactivated vaccine.
http://timesofindia.indiatimes.com/...n-state/articleshow/6488381.cms#ixzz0yVD1NpZC